Harbin Medisan Pharmaceutical Co., Ltd

Harbin Medisan Pharmaceutical is a national high-tech enterprise engaged in R&D, manufacturing and sales of chemical pharmaceutical finished dosage forms and APIs, operating four wholly owned subsidiaries and one joint stock company with registered capital of 211 million yuan. The company operates 13 production lines with capacity for 30 million vials of small-volume injections, 150 million vials of lyophilized powder for injection, 150 million tablets/capsules, 300 million bottles/bags of infusion solution, and 4 metric tons of API annually, with main products including oxiracetam injection, alanyl glutamine injection, cerebroprotein hydrolysate for injection, and glucose and sodium chloride injections.